{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:44:56Z","timestamp":1786963496262,"version":"build-2736575974"},"reference-count":25,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej18-0153","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T18:03:08Z","timestamp":1553536988000},"page":"555-562","source":"Crossref","is-referenced-by-count":25,"title":["Circulating zinc-\u03b12-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment"],"prefix":"10.1507","volume":"66","author":[{"given":"Siyuan","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Mai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanling","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijuan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Yang M, Liu R, Li S, Luo Y, Zhang Y, et al. (2013) Zinc-\u03b12-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes. Diabetes Care 36: 1074\u20131082.","DOI":"10.2337\/dc12-0940"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Yeung DCY, Lam KSL, Wang Y, Tso AWK, Xu A (2009) Serum zinc-\u03b12-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. J Clin Endocrinol Metab 94: 2531\u20132536.","DOI":"10.1210\/jc.2009-0058"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Balaz M, Vician M, Janakova Z, Kurdiova T, Surova M, et al. (2014) Subcutaneous adipose tissue zinc-\u03b12-glycoprotein is associated with adipose tissue and whole-body insulin sensitivity. Obesity (Silver Spring) 22: 1821\u20131829.","DOI":"10.1002\/oby.20764"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ceperuelo-Mallafre V, Naef S, Escote X, Caubet E, Gomez JM, et al. (2009) Circulating and adipose tissue gene expression of zinc-\u03b12-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. J Clin Endocrinol Metab 94: 5062\u20135069.","DOI":"10.1210\/jc.2009-0764"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Lai Y, Chen J, Li L, Yin J, He J, et al. (2016) Circulating zinc-\u03b12-glycoprotein levels and insulin resistance in polycystic ovary syndrome. Sci Rep 6: 25934.","DOI":"10.1038\/srep25934"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Qu C, Zhou X, Yang G, Li L, Liu H, et al. (2016) The natural logarithm of zinc-\u03b12-glycoprotein\/HOMA-IR is a better predictor of insulin sensitivity than the product of triglycerides and glucose and the other lipid ratios. Cytokine 79: 96\u2013102.","DOI":"10.1016\/j.cyto.2015.12.024"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"8","unstructured":"8 Chen C, Lu FC (2004) The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 17: 1\u201336."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Russell ST, Tisdale MJ (2011) Studies on the anti-obesity activity of zinc-\u03b12-glycoprotein in the rat. Int J Obes (Lond) 35: 658\u2013665.","DOI":"10.1038\/ijo.2010.193"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Mracek T, Stephens NA, Gao D, Bao Y, Ross JA, et al. (2011) Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br J Cancer 104: 441\u2013447.","DOI":"10.1038\/sj.bjc.6606083"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Bing C, Mracek T, Gao D, Trayhurn P (2010) Zinc-\u03b12-glycoprotein: an adipokine modulator of body fat mass & quest. Int J Obes (Lond) 34: 1559\u20131565.","DOI":"10.1038\/ijo.2010.105"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Mracek T, Ding Q, Tzanavari T, Kos K, Pinkney J, et al. (2010) The adipokine zinc-\u03b12-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf) 72: 334\u2013341.","DOI":"10.1111\/j.1365-2265.2009.03658.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Rolli V, Radosavljevic M, Astier V, Macquin C, Castan-Laurell I, et al. (2007) Lipolysis is altered in MHC class I zinc-\u03b12-glycoprotein deficient mice. FEBS Lett 581: 394\u2013400.","DOI":"10.1016\/j.febslet.2006.12.047"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Eckardt K, Schober A, Platzbecker B, Mracek T, Bing C, et al. (2011) The adipokine zinc-\u03b12-glycoprotein activates AMP kinase in human primary skeletal muscle cells. Arch Physiol Biochem 117: 88\u201393.","DOI":"10.3109\/13813455.2011.560950"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Gao D, Trayhurn P, Bing C (2010) Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes. Mol Cell Endocrinol 325: 135\u2013142.","DOI":"10.1016\/j.mce.2010.05.020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Li H, Xu X, Wang X, Liao X, Li L, et al. (2016) Free androgen index and Irisin in polycystic ovary syndrome. J Endocrinol Invest 39: 549\u2013556.","DOI":"10.1007\/s40618-015-0403-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R (2002) Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26: 883\u2013896.","DOI":"10.1038\/sj.ijo.0801994"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, et al. (2009) Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. J Clin Endocrinol Metab 94: 1973\u20131978.","DOI":"10.1210\/jc.2008-2583"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Gallwitz B (2014) Extra-pancreatic effects of incretin-based therapies. Endocrine 47: 360\u2013371.","DOI":"10.1007\/s12020-014-0223-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R (2008) Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 93: 2670\u20132678.","DOI":"10.1210\/jc.2008-0115"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Jensterle M, Kravos NA, Pfeifer M, Kocjan T, Janez A (2015) A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome. Hormones (Athens) 14: 81\u201390.","DOI":"10.1007\/BF03401383"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Jensterle M, Salamun V, Kocjan T, Vrtacnik Bokal E, Janez A (2015) Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study. J Ovarian Res 8: 32.","DOI":"10.1186\/s13048-015-0161-3"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Jensterle Sever M, Kocjan T, Pfeifer M, Kravos NA, Janez A (2014) Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin. Eur J Endocrinol 170: 451\u2013459.","DOI":"10.1530\/EJE-13-0797"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Zheng SY, Zhang Y, Long T, Lu JH, Liu X, et al. (2017) Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight\/obese PCOS women. Obes Med 7: 15\u201320.","DOI":"10.1016\/j.obmed.2017.06.003"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Liu X, Zhang Y, Zheng SY, Lin R, Xie YJ, et al. (2017) Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome. Clin Endocrinol (Oxf) 87: 767\u2013774.","DOI":"10.1111\/cen.13454"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/6\/66_EJ18-0153\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T23:36:55Z","timestamp":1561765015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/6\/66_EJ18-0153\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0153","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}